62 related articles for article (PubMed ID: 28460265)
1. Iron-Refractory Iron Deficiency Anemia with Novel TMPRSS6 Mutation.
Huang DW; He GQ; Guo X; Wan Z; Gao J; Yang R
Indian J Pediatr; 2024 Mar; 91(3):311. PubMed ID: 38052955
[No Abstract] [Full Text] [Related]
2. Association of SNPs within TMPRSS6 and BMP2 genes with iron deficiency status in Saudi Arabia.
Al-Amer OM; Oyouni AAA; Alshehri MA; Alasmari A; Alzahrani OR; Aljohani SAS; Alasmael N; Theyab A; Algahtani M; Al Sadoun H; Alsharif KF; Hamad A; Abdali WA; Hawasawi YM
PLoS One; 2021; 16(11):e0257895. PubMed ID: 34780475
[TBL] [Abstract][Full Text] [Related]
3. Normalizing hepcidin predicts
Heeney MM; Guo D; De Falco L; Campagna DR; Olbina G; Kao PP; Schmitz-Abe K; Rahimov F; Gutschow P; Westerman K; Ostland V; Jackson T; Klaassen RJ; Markianos K; Finberg KE; Iolascon A; Westerman M; London WB; Fleming MD
Blood; 2018 Jul; 132(4):448-452. PubMed ID: 29895660
[No Abstract] [Full Text] [Related]
4. Genomics of iron refractory iron deficiency anemia phenotype reveals a spectrum of novel pathogenic biallelic and monoallelic TMPRSS6 variants and rare overlapping disorders.
Sharma P; Bhatia P; Singh M; Das R; Attri SV; Ghara N; Prasada LH; Trehan A
Gene; 2024 Feb; 895():147981. PubMed ID: 37951373
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of TMPRSS6 catalytic domain variants in Mexican patients with iron treatment refractoriness.
Hernández-Peña R; Maciel-Cruz EJ; Rizo-De La Torre LDC; Perea-Díaz FJ; Ibarra-Cortés B
Lab Med; 2024 May; 55(3):277-284. PubMed ID: 37578538
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of Severe Iron Deficiency Anemia in Adolescent Girls with Exonic Variants Linked to Membranopathies.
Dantham S; Gaddam I
Indian J Pediatr; 2024 Jun; 91(6):641. PubMed ID: 38592584
[No Abstract] [Full Text] [Related]
7. The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease.
De Falco L; Tortora R; Imperatore N; Bruno M; Capasso M; Girelli D; Castagna A; Caporaso N; Iolascon A; Rispo A
Am J Hematol; 2018 Mar; 93(3):383-393. PubMed ID: 29194702
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum retention of xylosyltransferase 1 (XYLT1) mutants underlying Desbuquois dysplasia type II.
Al-Jezawi NK; Ali BR; Al-Gazali L
Am J Med Genet A; 2017 Jul; 173(7):1773-1781. PubMed ID: 28462984
[TBL] [Abstract][Full Text] [Related]
9. A novel MERTK mutation causing retinitis pigmentosa.
Al-Khersan H; Shah KP; Jung SC; Rodriguez A; Madduri RK; Grassi MA
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1613-1619. PubMed ID: 28462455
[TBL] [Abstract][Full Text] [Related]
10. The role of TMPRSS6 gene polymorphism in iron resistance iron deficiency anaemia (IRIDA): a systematic review.
Sharma A; Kumar A; Saha PK; Saha L
Ann Hematol; 2024 Apr; 103(4):1085-1102. PubMed ID: 38072851
[TBL] [Abstract][Full Text] [Related]
11. The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice.
Enns CA; Jue S; Zhang AS
Blood; 2020 Aug; 136(8):989-1001. PubMed ID: 32384154
[TBL] [Abstract][Full Text] [Related]
12. A Rare Case of Plummer-Vinson Syndrome.
Gade AK; Pacheco L
Cureus; 2019 Dec; 11(12):e6463. PubMed ID: 32025392
[TBL] [Abstract][Full Text] [Related]
13. Screening umbilical cord blood for congenital Iron deficiency.
MacQueen BC; Christensen RD; Baer VL; Ward DM; Snow GL
Blood Cells Mol Dis; 2019 Jul; 77():95-100. PubMed ID: 31005753
[TBL] [Abstract][Full Text] [Related]
14. The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin.
Mao P; Wortham AM; Enns CA; Zhang AS
J Biol Chem; 2019 Feb; 294(6):2060-2073. PubMed ID: 30559294
[TBL] [Abstract][Full Text] [Related]
15. Functional diversity of TMPRSS6 isoforms and variants expressed in hepatocellular carcinoma cell lines.
Dion SP; Béliveau F; Morency LP; Désilets A; Najmanovich R; Leduc R
Sci Rep; 2018 Aug; 8(1):12562. PubMed ID: 30135444
[TBL] [Abstract][Full Text] [Related]
16. Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.
Meznarich JA; Draper L; Christensen RD; Yaish HM; Luem ND; Pysher TJ; Jung G; Nemeth E; Ganz T; Ward DM
Blood Cells Mol Dis; 2018 Jul; 71():63-66. PubMed ID: 29599085
[TBL] [Abstract][Full Text] [Related]
17. Two novel mutations in TMPRSS6 associated with iron-refractory iron deficiency anemia in a mother and child.
Yaish HM; Farrell CP; Christensen RD; MacQueen BC; Jackson LK; Trochez-Enciso J; Kaplan J; Ward DM; Salah WK; Phillips JD
Blood Cells Mol Dis; 2017 Jun; 65():38-40. PubMed ID: 28460265
[TBL] [Abstract][Full Text] [Related]
18. A child with severe iron-deficiency anemia and a complex TMPRSS6 genotype.
Capra AP; Ferro E; Cannavò L; La Rosa MA; Zirilli G
Hematology; 2017 Oct; 22(9):559-564. PubMed ID: 28447549
[TBL] [Abstract][Full Text] [Related]
19. Iron refractory iron deficiency anemia: presentation with hyperferritinemia and response to oral iron therapy.
Khuong-Quang DA; Schwartzentruber J; Westerman M; Lepage P; Finberg KE; Majewski J; Jabado N
Pediatrics; 2013 Feb; 131(2):e620-5. PubMed ID: 23319530
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
